Phase II Study Evaluating the Role of Pazopanib in Angiosarcoma
Phase of Trial: Phase II
Latest Information Update: 03 Feb 2017
At a glance
- Drugs Pazopanib (Primary)
- Indications Haemangiosarcoma
- Focus Therapeutic Use
- 24 Jan 2017 Planned primary completion date changed from 1 Dec 2017 to 15 Dec 2018.
- 01 Mar 2016 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017 as reported by ClinicalTrials.gov record.
- 20 Nov 2013 Additional lead trial centre added as reported by ClinicalTrials.gov record.